To save lives by raising awareness of prostate cancer and by funding cutting-edge research.
The Mike Slive Foundation for Prostate Cancer Research makes pilot grants for innovative prostate cancer studies, with a peer-review process modeled after the NIH. Its program is designed to fund proof-of-concept work that can help researchers compete for larger federal grants later. The foundation’s grantmaking is tightly centered on prostate cancer research, with an emphasis on screening, metastatic disease, and projects that can move into broader competitive support. Recent awards show a clear research-institution profile. In 2025, the foundation gave $100,000 to The Regents of The University of California Los Angeles for prostate cancer research projects and another $100,000 to Icahn School of Medicine at Mount Sinai for the same purpose. It also made $50,000 grants to Fred Hutchinson Cancer Center, University of Maryland Baltimore, Duke University, Indiana University, The University of Iowa, University of Texas MD Anderson Cancer Center, and Stanford University, all for prostate cancer research projects. The foundation’s stated aim is to save lives by raising awareness of prostate cancer and funding cutting-edge research.
The foundation’s work is centered on prostate cancer research grants, especially pilot studies that can generate proof-of-concept data. It gave $50,000 to Fred Hutchinson Cancer Center for prostate cancer research projects, reflecting support for institutional research teams. It also backs major academic medical centers working on the disease. University of Maryland Baltimore received $50,000 for prostate cancer research projects, while University of Texas MD Anderson Cancer Center received the same amount for that purpose. Another part of its grantmaking supports research at universities with broad biomedical capacity. The foundation awarded $50,000 to The University of Iowa for prostate cancer research projects and $50,000 to Stanford University for the same purpose. The active program description also points to screening and metastatic prostate cancer within its research focus.
The active Research Grant Program uses a fixed grant size of $50,000, while the most recent awards also include $100,000 grants. The peer-review process is modeled after the NIH, and the program is intended to help researchers produce proof-of-concept results for later federal applications. The recent grants list shows a 2025-only pattern in the data provided, with all nine recent awards going to U.S. recipients. The foundation is a public charity, funds institutions rather than individuals, and accepts unsolicited applications for its research program.
$550K
$1.2M
$574K
$747K
About 0% of grants go to recipients in CA.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeRegístrate gratis para ver qué tan bien se adapta tu organización sin fines de lucro a este financiador, obtener un pitch generado por IA y descubrir fundaciones similares.
Recent grants are distributed across U.S. research centers rather than concentrated in Alabama. The most visible recipient cities in the data include Los Angeles, New York, Seattle, Baltimore, Charlotte, Detroit, Iowa City, Houston, and El Monte. The grants list shows 9 of 9 awards to U.S. recipients, or 100% in the United States. No recipient in the recent-grants list is located in Alabama.
It funds prostate cancer research, with an active Research Grant Program for innovative pilot studies, proof-of-concept work, prostate cancer screening, and metastatic prostate cancer. The foundation’s stated aim is to save lives by raising awareness of prostate cancer and funding cutting-edge research.
Yes. The active Research Grant Program accepts unsolicited applications and uses a peer-review process modeled after the NIH.
The recent grants list shows awards to research institutions and universities, including The Regents of The University of California Los Angeles, Icahn School of Medicine at Mount Sinai, Fred Hutchinson Cancer Center, and Stanford University. The foundation does not fund individuals.
The active Research Grant Program provides pilot grants of $50,000. In the most recent grant list, most awards are $50,000, with two $100,000 grants also shown.
The recent-grants data shows all 9 awards going to U.S. recipients. Named recipient cities include Los Angeles, New York, Seattle, Baltimore, Charlotte, Detroit, Iowa City, Houston, and El Monte.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Financiamiento actual y próximo de Mike Slive Foundation for Prostate Cancer Research al que tu organización sin fines de lucro podría postularse.
¿Quién puede postularse? Applicants should be conducting innovative prostate cancer research. The program uses a peer-review process and has expanded to institutions in ten additional Southeastern states, with plans for nationwide expansion.
Fecha límite: The submission deadline has been updated to September 8th, 2026.
Haz seguimiento de estas fechas límite, recibe recordatorios y descubre qué tan bien encaja tu organización — gratis con una cuenta de Kindora.
Crea una cuenta gratisLas fechas límite y los requisitos de elegibilidad son un resumen de fuentes públicas y pueden cambiar — confirma siempre los detalles en la página oficial de solicitud del financiador antes de postularte.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| The Regents of The University of California Los Angeles | Los Angeles, CA | $100,000 | 2025 | To support prostate cancer research projects. |
| Icahn School of Medicine at Mount Sinai | New York, NY | $100,000 | 2025 | To support prostate cancer research projects. |
| Fred Hutchinson Cancer Center | Seattle, WA | $50,000 | 2025 | To support prostate cancer research projects. |
| University of Maryland Baltimore | Baltimore, MD | $50,000 | 2025 | To support prostate cancer research projects. |
| University of Texas MD Anderson Cancer Center | Houston, TX | $50,000 | 2025 | To support prostate cancer research projects. |
| Indiana University | Detriot, MI | $50,000 | 2025 | To support prostate cancer research projects. |
| The University of Iowa | Iowa City, IA | $50,000 | 2025 | To support prostate cancer research projects. |
| Duke University | Charlotte, NC | $50,000 | 2025 | To support prostate cancer research projects. |
| Stanford University | El Monte, CA | $50,000 | 2025 | To support prostate cancer research projects. |
| O'Neal Comprehensive Cancer Center at UAB | Birmingham, AL | $160,000 | 2024 | To support prostate cancer research projects. |
The Regents of The University of California Los Angeles
$100,000To support prostate cancer research projects.
To support prostate cancer research projects.
University of Maryland Baltimore
$50,000To support prostate cancer research projects.
University of Texas MD Anderson Cancer Center
$50,000To support prostate cancer research projects.
Indiana University
To support prostate cancer research projects.
To support prostate cancer research projects.